Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 679

1.

Healthcare utilization and costs for patients initiating Dabigatran or Warfarin.

Reynolds SL, Ghate SR, Sheer R, Gandhi PK, Moretz C, Wang C, Sander S, Costantino ME, Annavarapu S, Andrews G.

Health Qual Life Outcomes. 2017 Jun 21;15(1):128. doi: 10.1186/s12955-017-0705-x.

2.

Paradigm shift in anticoagulation therapy, fueling the pump and preventing rhythm crisis.

Ohene BE, Gao F, Zhou YJ.

J Thorac Dis. 2017 May;9(5):E444-E446. doi: 10.21037/jtd.2017.04.60. No abstract available.

3.

Empirical anticoagulation for patients in sinus rhythm at high risk of ischaemic stroke: A review of current literature.

Battipaglia I, O'Neill J, Hogarth AJ, Tayebjee MH.

World J Cardiol. 2017 May 26;9(5):422-428. doi: 10.4330/wjc.v9.i5.422. Review.

4.

Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation.

Park Y, Kim KH, Kang MG, Ahn JH, Jang JY, Park HW, Koh JS, Park JR, Hwang SJ, Jeong YH, Hwang JY, Lee HR, Kwak CH.

Korean Circ J. 2017 May;47(3):366-376. doi: 10.4070/kcj.2016.0384. Epub 2017 May 25.

5.

Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation.

Magalhães LP, Figueiredo MJO, Cintra FD, Saad EB, Kuniyoshi RR, Menezes Lorga Filho A, D'Avila ALB, Paola AAV, Kalil CAA, Moreira DAR, Sobral Filho DC, Sternick EB, Darrieux FCDC, Fenelon G, Lima GG, Atié J, Mateos JCP, Moreira JM, Vasconcelos JTM.

Arq Bras Cardiol. 2016 Dec;107(6):501-508. doi: 10.5935/abc.20160190. Portuguese, English. No abstract available.

6.

Stroke Prevention in Atrial Fibrillation: Focus on Latin America.

Massaro AR, Lip GYH.

Arq Bras Cardiol. 2016 Dec;107(6):576-589. doi: 10.5935/abc.20160116. Epub 2016 Aug 11. Portuguese, English.

7.

Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study.

Ording AG, Horváth-Puhó E, Adelborg K, Pedersen L, Prandoni P, Sørensen HT.

Cancer Med. 2017 Jun;6(6):1165-1172. doi: 10.1002/cam4.1054. Epub 2017 May 19.

8.

Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation.

Antoniou S, Amara W.

Eur Heart J Suppl. 2016 Apr 20;18(Suppl D):D7-D15. doi: 10.1093/eurheartj/suv061.

9.

Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Amara W, Antoniou S.

Eur Heart J Suppl. 2016 Apr 20;18(Suppl D):D1-D6. doi: 10.1093/eurheartj/suv062. Epub 2016 Apr 21.

10.

Perioperative management of patients on direct oral anticoagulants.

Dubois V, Dincq AS, Douxfils J, Ickx B, Samama CM, Dogné JM, Gourdin M, Chatelain B, Mullier F, Lessire S.

Thromb J. 2017 May 15;15:14. doi: 10.1186/s12959-017-0137-1. eCollection 2017. Review.

11.

Trithérapie antithrombotique pour la fibrillation auriculaire et les endoprothèses coronariennes.

Shmyr D, Van der Merwe V, Yakiwchuk E, Barry A, Kosar L.

Can Fam Physician. 2017 May;63(5):e269-e276. French. No abstract available.

PMID:
28500209
Free PMC Article
12.

Triple antithrombotic therapy for atrial fibrillation and coronary stents.

Shmyr D, Van der Merwe V, Yakiwchuk E, Barry A, Kosar L.

Can Fam Physician. 2017 May;63(5):375-381. No abstract available.

13.

Safety of The Direct Oral Anticoagulant Edoxaban for Atrial Fibrillation After Cardiac Surgery: Pilot Study.

Sezai A, Osaka S, Yaoita H, Arimoto M, Hata H, Shiono M.

J Atr Fibrillation. 2016 Oct 31;9(3):1456. doi: 10.4022/jafib.1456. eCollection 2016 Oct-Nov.

14.

Anticoagulation and Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation: Findings From the ADHERE Registry.

Eapen ZJ, Mi X, Fonarow GC, Setoguchi S, Piccini JP, Mills RM, Klaskala W, Curtis LH, Hernandez AF.

J Atr Fibrillation. 2013 Dec 31;6(4):953. doi: 10.4022/jafib.953. eCollection 2013 Dec.

15.

Advances in Left Atrial Appendage Occlusion Strategies.

Aryana A, Singh SM, Doshi SK, d'Avila AA.

J Atr Fibrillation. 2013 Dec 31;6(4):929. doi: 10.4022/jafib.929. eCollection 2013 Dec. Review.

16.

Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Nonrheumatic Atrial Fibrillation.

Sick PB.

J Atr Fibrillation. 2013 Oct 31;6(3):923. doi: 10.4022/jafib.923. eCollection 2013 Oct-Nov. Review.

17.

Atrial Fibrillation - A Common Ground for Neurology and Cardiology.

Abukhalil F, Bodhit A, Cai PY, Ansari S, Thenkabail S, Ganji S, Saravanapavan P, Chandra Shekhar C, Waters MF, Beaver TM, Shushrutha Hedna V.

J Atr Fibrillation. 2013 Aug 31;6(2):550. doi: 10.4022/jafib.550. eCollection 2013 Aug-Sep. Review.

18.

Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial Fibrillation.

Rillig A, Lin T, Ouyang F, Heinz Kuck K, Richard Tilz R.

J Atr Fibrillation. 2013 Jun 30;6(1):861. doi: 10.4022/jafib.861. eCollection 2013 Jun-Jul. Review.

19.

Pharmacological Therapy in Stroke Prophylaxis - The New versus the Old Agents.

Maan A, Heist EK, Ruskin JN, Mansour M.

J Atr Fibrillation. 2013 Jun 30;6(1):825. doi: 10.4022/jafib.825. eCollection 2013 Jun-Jul. Review.

20.

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants.

Mitrousi K, Lip GYH, Apostolakis S.

J Atr Fibrillation. 2013 Jun 30;6(1):783. doi: 10.4022/jafib.783. eCollection 2013 Jun-Jul. Review.

Supplemental Content

Support Center